Statistical Reporting in Plastic Surgery Research Authors: Mohamed Badie Ahmed, Abeer Alsherawi, Suhail A. Doi Published: 2026 ABSTRACT Summary:Current discussions in plastic surgery research highlight the need for improved statistical reporting to enhance clarity and accuracy. Although existing literature addresses common reporting issues, this communication emphasizes the critical role of language in statistical interpretation. Terms like “statistical significance” and “confidence intervals” often mislead by implying importance and certainty, respectively. Instead, adopting “statistical divergence” and “uncertainty intervals” would better reflect their true meanings—divergence from a null model and uncertainty in parameter estimates. Moving beyond the rigid 0.05 threshold, a continuous interpretation of P values could reduce binary thinking, mitigate P-hacking, and improve transparency in small-sample studies. Additionally, redefining confidence intervals as uncertainty intervals would correct common misconceptions about their probabilistic nature. To address these issues, we recommend that journals provide clear author guidelines promoting precise terminology and framing statistical results in terms of divergence and uncertainty. Aligning language with statistical reality will reduce misinterpretation and strengthen research quality in plastic surgery. Takeaways Question: How can statistical reporting in plastic surgery research be improved to reduce misinterpretation and better reflect the true meaning of P values and interval estimates? Findings: This communication critiques commonly used terms such as “statistical significance” and “confidence intervals,” showing that they contribute to misconceptions. It proposes using “statistical divergence” and “uncertainty intervals” to better represent divergence from a null model and uncertainty in estimates, and recommends continuous interpretation of P values rather than threshold-based decisions. Meaning: Adopting clearer terminology and reporting practices can reduce misunderstanding, discourage binary thinking, and strengthen scientific transparency in plastic surgery research. INTRODUCTION Interest in improving reporting standards in plastic surgery research is increasing. Prior work highlighted interpretation challenges,1 but reform should also address statistical language.2 Because surgical research compares group differences, statistical inference is essential to quantify uncertainty and support clinical interpretation. First, the terms “null hypothesis,” better called “tested hypothesis,” implies a sampling distribution of repeated samples of the same size from a single population where each sample is represented by its sample statistic (mean) plotted as a histogram. The histogram is usually a normal distribution centered on the assumed population value from which the distribution spreads out due to random error only. Second, a test of significance generates the P value and must be distinguished from a hypothesis test used solely for sample size calculation. All P values in surgical research arise from tests of significance. When the P value falls below a predefined threshold, results are labeled “statistically significant,” a term that misleadingly implies importance rather than simple divergence from the tested (null) hypothesis distribution. Recent proposals recommend reforming statistical terminology by replacing “statistical significance” with “statistical divergence,” as suggested by Zar et al.2 This terminology more accurately reflects that findings represent divergence from the tested hypothesis without implying clinical importance or value of the estimated effect.2 This recommendation applies to all analytical study designs including those observational designs commonly used in plastic surgery research. Rigid adherence to the 0.05 threshold reinforces binary interpretation of results. Zar et al proposed viewing P values as degrees of statistical divergence rather than pass/fail outcomes. This continuous framework may reduce P-hacking, publication bias, and stigma surrounding borderline or null findings, particularly in small-sample plastic surgery research. Third, many authors mistakenly interpret confidence intervals as ranges containing the true parameter. The standard definition of the interval is that over many study replications resulting in many such intervals, 95% will capture the unknown population parameter. In reality, the actual study interval of interest may not include the true value. Any single interval will not even have a 95% probability of containing the true parameter because the 95% refers to a long run probability concerning all the intervals and occurs before a particular interval of interest is realized. The name “confidence” is confusing because it reflects certainty about parameter estimates rather than uncertainty.3 This has led to a great deal of misinterpretation and to avoid all this, we strongly advocate use of the term “uncertainty interval” instead of “confidence interval.”2 The interpretation can then be defined in terms of the study interval as a range of test hypotheses under each of which the study test statistic falls in their central 95% of values.2 In simple terms, an uncertainty interval represents the range of test hypotheses under which study data are not unusual, meaning observed effects fall within the central 95% of expected values under random error. The interval lists means of hypothesized sampling distributions, defining plausible population parameter estimates consistent with the data. Because no single value within this range can be considered certain, it appropriately reflects uncertainty in estimation. The interval corresponds directly to significance testing, containing all hypothesized parameter values that would not be rejected in a two-sided 5% test. For example, a 95% interval of 2 to 6 includes all hypotheses yielding fail-to-reject results, making uncertainty intervals more informative than significance tests alone. APPLIED EXAMPLE Wahdan et al evaluated the aesthetic outcomes after laser-assisted liposuction for gynecomastia.4 The authors reported significantly higher BREAST-Q scores in group 2 compared with group 1 (P < 0.005), indicating statistical divergence from a null hypothesis of 0 difference. However, statistical significance alone does not convey the magnitude or clinical importance of the effect, which could still be very small. If an uncertainty interval had been provided—for example, a mean difference of 2 points with a 95% uncertainty interval of 0.1 to 3.9—it would demonstrate that, although the result remains statistically divergent (as 0 is excluded), the effect lies within the range of clinical indifference (<4 points). Thus, uncertainty intervals better communicate both effect size and clinical relevance than reliance on the P value alone and should be routinely reported. As another example, Figure 1 depicts 6 hypothetical uncertainty intervals based on 6 different studies answering the question set out by Wahdan et al.4 Each uncertainty interval can be interpreted differently (Table 1). Table 1.Interpretation of BREAST-Q Score Differences Using a Clinical Indifference Range of ±5 Points; Statistical Divergence Does Not Necessarily Indicate Benefit, and Nondivergence Does Not Exclude a Meaningful Clinical EffectFigure LocationPrevious LanguageNew Proposed LanguageFigure 1aLaser-assisted liposuction shows a statistically significant benefit (BREAST-Q score difference: 10; 95% CI, 8–12; P < 0.001)This result is interpreted as a statistically divergent estimated effect representing a moderate and clinically important benefitFigure 1bLaser-assisted liposuction shows a statistically significant benefit (BREAST-Q score difference: 2.5; 95% CI, 2–3; P < 0.001)This result is interpreted as a statistically divergent estimated effect that is clinically unimportant trivial and falls within the range of clinical indifference (this is probably where the result of Wahdan et al may possibly lie had they provided an interval estimate)Figure 1cLaser-assisted liposuction shows a statistically significant benefit (BREAST-Q score difference: 16; 95% CI, 2.5–29.5; P = 0.020)This result is interpreted as a statistically divergent estimated effect representing an uncertain practical benefit due to wide uncertainty intervals crossing thresholds of clinical importanceFigure 1dLaser-assisted liposuction shows no statistically significant benefit (BREAST-Q score difference: 0; 95% CI, −2.5 to 2.5; P = 1.00)This result is interpreted as a statistically nondivergent estimated effect indicating no clinically meaningful benefitFigure 1eLaser-assisted liposuction shows no statistically significant benefit (BREAST-Q score difference: 20; 95% CI, −1 to 41; P = 0.062)This result is interpreted as a statistically nondivergent estimated effect with a point estimate suggesting a potentially large clinical benefit, reflecting uncertainty rather than the absence of effect.Figure 1fLaser-assisted liposuction shows no statistically significant benefit (BREAST-Q score difference: 7; 95% CI, −1 to 15; P = 0.086)This result is interpreted as a statistically nondivergent estimated effect suggesting a possible moderate clinical benefit, again reflecting uncertainty rather than the absence of effect Interpretation of BREAST-Q Score Differences Using a Clinical Indifference Range of ±5 Points; Statistical Divergence Does Not Necessarily Indicate Benefit, and Nondivergence Does Not Exclude a Meaningful Clinical Effect Vertical lines represent uncertainty intervals for 6 hypothetical studies comparing conventional vs laser-assisted liposuction, with dashed lines indicating the clinical indifference range (±5 BREAST-Q points) and the solid line the null effect. Although studies are classified as statistically divergent (a–c) or nondivergent (d–f), both groups demonstrate variability in clinical relevance. RECOMMENDATIONS In plastic surgery research, the interpretation of P values and the traditional dichotomy of “significant” versus “nonsignificant” findings has increasingly been reexamined. Several recent articles5–7 have highlighted how reliance on this simplified framework can sometimes obscure clinically meaningful effects, or convey a level of certainty that the data may not fully support. As the field moves toward greater emphasis on effect sizes, uncertainty intervals, and the overall strength of evidence rather than strict reliance on arbitrary thresholds, it becomes increasingly important to consider how statistical results are communicated and interpreted. This perspective has been reinforced by the American Statistical Association’s 2016 statement8 and other commentaries9 which caution against common misinterpretations of P values. Specifically, we recommend standardized instructions adapted from Zar et al2: “P values were computed to determine if the study results were consistent with a sampling probability model of the population that assumes no effect (tested hypothesis). As the P value gets smaller than 1, divergence of the study result from the tested hypothesis increases. Once the P values is in the interval P < 0.05, we deemed this a ‘statistically divergent’ result indicating that our threshold for rejecting the tested hypothesis as the source of the study data was met. The point estimate and its 95% uncertainty interval were also reported to highlight the practical importance of the study result because the interval represents a range of hypothesized parameter values that remain plausible given the data at the chosen significance level.” Common statistical terms such as confidence, significance, and null hypothesis may be interpreted differently in everyday language. We propose complementary terminology—uncertainty, divergence, and tested hypothesis—to better reflect statistical concepts and improve clarity in reporting within surgical research. DISCLOSURES The authors have no financial interest to declare in relation to the content of this article.